These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Nephrogenic diabetes insipidus in children (Review). Duicu C; Pitea AM; Săsăran OM; Cozea I; Man L; Bănescu C Exp Ther Med; 2021 Jul; 22(1):746. PubMed ID: 34055061 [TBL] [Abstract][Full Text] [Related]
47. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505 [TBL] [Abstract][Full Text] [Related]
48. Lithium-induced nephrogenic diabetes insipidus. Stone KA J Am Board Fam Pract; 1999; 12(1):43-7. PubMed ID: 10050642 [TBL] [Abstract][Full Text] [Related]
49. Physiopathology and diagnosis of nephrogenic diabetes insipidus. Devuyst O Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803 [TBL] [Abstract][Full Text] [Related]
50. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study. García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G; Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753 [TBL] [Abstract][Full Text] [Related]
51. Hydrochlorothiazide, amiloride and tolmetin in the treatment of diabetes insipidus of Brattleboro rats. Alon U; Wellons MD; Chan JC Med Biol; 1985; 63(3):117-22. PubMed ID: 4068772 [TBL] [Abstract][Full Text] [Related]
52. A novel mutation in the AVPR2 gene (222delA) associated with X-linked nephrogenic diabetes insipidus in a boy with growth failure. Abaci A; Wood K; Demir K; Büyükgebiz A; Böber E; Kopp P Endocr Pract; 2010; 16(2):231-6. PubMed ID: 19703807 [TBL] [Abstract][Full Text] [Related]
53. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus. Moosavi SM; Karimi Z Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797 [TBL] [Abstract][Full Text] [Related]
54. Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus. Monn E Acta Paediatr Scand; 1981 Jan; 70(1):39-42. PubMed ID: 6782828 [TBL] [Abstract][Full Text] [Related]
55. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin. Andersen O; Jacobsen BB Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470 [TBL] [Abstract][Full Text] [Related]
58. Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma. Zaki M; Schöneberg T; Al Ajrawi T; Al Said AN; Sangkuhl K; Römpler H Nephrol Dial Transplant; 2006 Apr; 21(4):1082-6. PubMed ID: 16423865 [No Abstract] [Full Text] [Related]
59. Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis. Uwumugambi NA; Sanchorawala V; Shelton AC; Stern L; Gordon CE Am J Kidney Dis; 2017 Feb; 69(2):317-319. PubMed ID: 27780577 [TBL] [Abstract][Full Text] [Related]